Trevor Hawkins will join MDS as chief science and technology officer, a newly created position at the company, on May 2. Hawkins will report to John Rogers, president and CEO of MDS. Hawkins most recently served as president of the molecular diagnostics business unit at GE Healthcare. Previously, he was senior vice president of development and new business initiatives at Amersham Biosciences and director of the Human Genome Project at the Department of Energy's Joint Genome Institute.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.